Travere Therapeutics
The Chief Research Officer provides enterprise leadership for Research, Clinical Operations, Clinical Supplies, Clinical Pharmacology, and Biometrics at Travere Therapeutics. This role shapes the long-term research agenda and pipeline strategy while connecting early scientific work with rigorous clinical execution. The position involves strategic advisory to executive leadership, overseeing global clinical trial delivery, and ensuring high-quality evidence generation across the rare disease portfolio.
Headquarters
San Diego, California, United States
Company Size
201-500 employees
Founded
2020
Travere Therapeutics is a biopharmaceutical company whose mission is to identify, develop and deliver life-changing therapies to people living with rare disease.
How Investors Are Reacting To Travere Therapeutics (TVTX) FILSPARI Momentum And Mirum Milestone Windfall
1 day ago
Piper Sandler Increases Target Price for Travere Therapeutics (TVTX)
3 days ago
Travere Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
3 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Travere Therapeutics.
Travere Therapeutics, Inc. (TVTX): A Bull Case Theory
2 weeks ago
Biostatistician (Part-Time)
Entrada Therapeutics
Clinical Scientist Rare Disease
Excelya
Senior Director, Clinical Research - Neurodegeneration
Alnylam Pharmaceuticals
Medical Science Liaison
Protara Therapeutics
Senior MSL – Rare Diseases (Haematology, Nephrology and Transplant)
AstraZeneca
Executive Director/Vice President, Medical Affairs – Genetic Rare Disease
Relay Therapeutics